Lamotrigine 200 mg/1 (Lamotrigine Extended-Release TABLET, FILM COATED, EXTENDED RELEASE) 200 mg/1

Lamotrigine 200 mg extended-release tablets are used to manage certain types of seizures and mood disorders. This extended-release formulation is designed for consistent medication delivery.

Strength

200 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-243-30)

Manufacturer / TM Owner

Camber Pharmaceuticals Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lamotrigine is primarily used as an anticonvulsant to control seizures in conditions like epilepsy. It is also prescribed for bipolar disorder to stabilize mood. The extended-release formulation helps maintain steady drug levels in the body. People often ask, 'What is lamotrigine used for?' and the answer includes seizure prevention and mood stabilization.

Side Effects

Common effects of lamotrigine may include dizziness, headache, and nausea. Some users report blurred vision or coordination issues. These effects vary and are not experienced by everyone.

Precautions & Warnings

Lamotrigine should be handled with care, especially when starting or adjusting the dose. It is important to follow medical guidance regarding its use. Sudden discontinuation can be harmful, so any changes should be discussed with a healthcare provider.

Avoid Interactions

Lamotrigine may interact with other medications, including certain anticonvulsants and hormonal birth control. Alcohol and other central nervous system depressants should be used cautiously. Always inform healthcare providers about all medications being taken.

Frequently Asked Questions

Lamotrigine is used to manage seizures in epilepsy and to stabilize mood in bipolar disorder.

The extended-release formulation is designed to release the medication slowly, maintaining consistent drug levels in the body.

Common side effects include dizziness, headache, nausea, and blurred vision.

Lamotrigine may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Sudden discontinuation of lamotrigine can be harmful. Any changes in dosage should be discussed with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.